Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Strategies for larger families focus on prioritization and flexible allocations. Learn how to tailor a zero-based plan to multiple dependents.
27,842 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A bold stake in a boutique asset-manager platform is sending ripples through the investing world. This article explai...
Strive raises the dividend on SATA preferred stock to 12.75% and deploys $50 million into Strategy's STRC, while incr...
Vanguard’s VTSAX has posted roughly a 300% gain over the last ten years, outpacing most active funds amid a tech-driv...
Markets confront a familiar riddle: the buffett paradox: world’s greatest investor preaches passive investing while B...
Traders are turning to a wheel-style IBIT options strategy that converts Bitcoin's volatility into premium. The appro...
SpaceX's market debut ignited a wave of aggressive bets on disruptive ideas. Investors pile into moonshot bets as opt...
When a large manager trims a position, questions follow. This article breaks down Hilton Capital’s $25 million GPIX s...
Metaplanet has agreed to acquire Siiibo Securities for $13 million, with a July closing window and a planned rebrand ...
The UN General Assembly passed a landmark, non-binding resolution labeling the slave trade as the gravest crime again...
Investors are weighing value exposure against high-quality income. This piece analyzes why SCHD may outperform VTV on...
WM Technology MAPS is weighing a pivotal year. This guide breaks down the Q4 2025 earnings, what technology (maps) 20...